MA25664A1 - Nouveau cristal stable de derive de thiazolidinedione et procede de sa fabrication. - Google Patents

Nouveau cristal stable de derive de thiazolidinedione et procede de sa fabrication.

Info

Publication number
MA25664A1
MA25664A1 MA26881A MA26881A MA25664A1 MA 25664 A1 MA25664 A1 MA 25664A1 MA 26881 A MA26881 A MA 26881A MA 26881 A MA26881 A MA 26881A MA 25664 A1 MA25664 A1 MA 25664A1
Authority
MA
Morocco
Prior art keywords
manufacture
novel stable
thiazolidinedione derivative
derivative crystal
crystal
Prior art date
Application number
MA26881A
Other languages
English (en)
Inventor
Ohnota Michiro
Orita Kazuo
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of MA25664A1 publication Critical patent/MA25664A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA26881A 2000-04-25 2002-10-25 Nouveau cristal stable de derive de thiazolidinedione et procede de sa fabrication. MA25664A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000124006 2000-04-25

Publications (1)

Publication Number Publication Date
MA25664A1 true MA25664A1 (fr) 2002-12-31

Family

ID=18634205

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26881A MA25664A1 (fr) 2000-04-25 2002-10-25 Nouveau cristal stable de derive de thiazolidinedione et procede de sa fabrication.

Country Status (23)

Country Link
US (1) US6770133B2 (fr)
EP (1) EP1277745A4 (fr)
KR (1) KR20030007548A (fr)
CN (1) CN1426402A (fr)
AU (1) AU4882801A (fr)
BG (1) BG107200A (fr)
BR (1) BR0110258A (fr)
CA (1) CA2407349A1 (fr)
CZ (1) CZ20023502A3 (fr)
EA (1) EA004244B1 (fr)
EE (1) EE200200601A (fr)
HK (1) HK1053835A1 (fr)
HU (1) HUP0300475A3 (fr)
IL (1) IL152224A0 (fr)
IS (1) IS6586A (fr)
MA (1) MA25664A1 (fr)
MX (1) MXPA02010545A (fr)
NO (1) NO20025069D0 (fr)
PL (1) PL365533A1 (fr)
SK (1) SK15142002A3 (fr)
WO (1) WO2001081327A1 (fr)
YU (1) YU80302A (fr)
ZA (1) ZA200208293B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057007A1 (fr) * 2000-02-01 2001-08-09 Kyorin Pharmaceutical Co., Ltd. Sel de metal alcalin de derive de thiazolidine-4,4-dione
WO2003062214A1 (fr) * 2002-01-23 2003-07-31 Kyorin Pharmaceutical Co., Ltd. Nouveau cristal stable de derive de benzylthiazolidinedione et procede de preparation de celui-ci
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CN1882327A (zh) 2003-11-19 2006-12-20 症变治疗公司 含磷的新的拟甲状腺素药
DE602004004631D1 (de) 2004-04-01 2007-03-22 Sanofi Aventis Deutschland Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
TWI383008B (zh) * 2005-08-17 2013-01-21 Nippon Catalytic Chem Ind 吸水性樹脂之製造方法及吸水性樹脂以及其利用
TW201336497A (zh) 2007-02-08 2013-09-16 Daiichi Sankyo Co Ltd 噻唑啶二酮化合物之結晶型及其製法
WO2010093601A1 (fr) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Nouveaux thyromimetiques contenant de l'acide sulfonique et methodes d'utilisation associees

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4864028A (en) * 1983-09-14 1989-09-05 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
JP3053490B2 (ja) 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−２，４−ジオン誘導体とその塩及び製造法
JPH04270273A (ja) 1991-02-25 1992-09-25 Kyorin Pharmaceut Co Ltd チアゾリジン−２，４−ジオン誘導体とその塩及びその製造法
JP3644998B2 (ja) * 1995-02-09 2005-05-11 塩野義製薬株式会社 ベンジリデン誘導体の結晶の選択的取得方法
US6001862A (en) * 1995-06-02 1999-12-14 Kyorin Pharameuticals Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same
US6147101A (en) * 1995-06-02 2000-11-14 Kyorin Pharmaceutical Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
JP3144624B2 (ja) 1995-06-02 2001-03-12 杏林製薬株式会社 Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
ZA971637B (en) * 1996-02-28 1997-09-25 Nissan Chemical Ind Ltd Thifluzamide with improved efficacy.
JPH101476A (ja) * 1996-02-28 1998-01-06 Nissan Chem Ind Ltd 効力が向上したチフルザミド
GB9726566D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
BR0110258A (pt) 2003-01-07
HUP0300475A3 (en) 2004-10-28
HK1053835A1 (en) 2003-11-07
AU4882801A (en) 2001-11-07
MXPA02010545A (es) 2004-05-14
IS6586A (is) 2002-10-21
EE200200601A (et) 2004-04-15
EA200201055A1 (ru) 2003-06-26
EA004244B1 (ru) 2004-02-26
NO20025069L (no) 2002-10-22
HUP0300475A2 (hu) 2003-06-28
CA2407349A1 (fr) 2002-10-24
SK15142002A3 (sk) 2003-04-01
WO2001081327A1 (fr) 2001-11-01
ZA200208293B (en) 2003-10-06
EP1277745A4 (fr) 2004-09-15
PL365533A1 (en) 2005-01-10
IL152224A0 (en) 2003-05-29
CN1426402A (zh) 2003-06-25
YU80302A (sh) 2005-11-28
CZ20023502A3 (cs) 2003-06-18
US6770133B2 (en) 2004-08-03
NO20025069D0 (no) 2002-10-22
KR20030007548A (ko) 2003-01-23
EP1277745A1 (fr) 2003-01-22
BG107200A (bg) 2003-11-28
US20030101925A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
MA25664A1 (fr) Nouveau cristal stable de derive de thiazolidinedione et procede de sa fabrication.
FR2822542B1 (fr) Capteur de temperature et procede pour sa fabrication
DK1326862T3 (da) Krystallinsk monohydrat af tiotropiumbromid, fremgangsmåde til fremstilling deraf og anvendelse deraf til fremstilling af et lægemiddel
DK1293507T3 (da) Fremgangsmåde til fremstilling af krystaller
EP1354581A4 (fr) Substance poreuse et son procede de fabrication
EP1335421A4 (fr) Procede de production de plaquette et plaquette
FR2813191B1 (fr) Derives du tocopherol et procede de preparation de ceux-ci
EP1202060A4 (fr) Biocapteur et procede de fabrication
FR2817745B1 (fr) Nuancier et procede de fabrication
FR2804681B1 (fr) Compose antidiabetique et procede pour sa production
EP1182451A4 (fr) Biocapteur et procede de production correspondant
EP1561561A4 (fr) Procede de production de film poreux et film poreux
EP1480260A4 (fr) Procede de fabrication de cristal
EP1471578A4 (fr) Procede de production de plaquette soi et plaquette soi
EP1222865A4 (fr) Ingredient pour cigarette et procede de fabrication
FI20001612L (fi) Menetelmä kuitulevyjen valmistamiseksi
NO20041850L (no) Fremgangsmate for dannelse av profenkrystaller
EP1354954A4 (fr) Procede de fabrication de prenyl alcool
EP1744378A4 (fr) Element monocristallin piezoelectrique et procede de fabrication de celui-ci
EP1270597A4 (fr) Acetate de cellulose et procede de production associe
EP1653287A4 (fr) Materiau de formation de micro-motifs et procede de formation de micro-motifs
FR2858618B1 (fr) Procede et reacteur de fabrication d'hydroxymethylfurfural
FR2816330B1 (fr) Monocristaux, procede de fabrication de monocristaux par croissance en solution et applications
EP1285961A4 (fr) Procede de formation in vitro de pancreas de vertebre
NO20023087D0 (no) Fremgangsmåte for fremstilling av kvartsdigler